SCIZOPHRENIA

Clinical trials for SCIZOPHRENIA explained in plain language.

Never miss a new study

Get alerted when new SCIZOPHRENIA trials appear

Sign up with your email to follow new studies for SCIZOPHRENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for managing troubling medication side effect

Disease control Not yet recruiting

This study aims to find out if a drug called cabergoline is safe for treating high prolactin levels, a common side effect of antipsychotic medications in people with schizophrenia. Researchers want to see if taking cabergoline for 12 weeks worsens schizophrenia symptoms compared …

Matched conditions: SCIZOPHRENIA

Phase: PHASE4 • Sponsor: Zealand University Hospital • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

SCIZOPHRENIA

Get alerted when new SCIZOPHRENIA trials appear

New hope for managing troubling medication side effect